Insight Molecular Diagnostics INC. (IMDX) — 10-Q Filings

10-Q Filings (6)

• IMDX Revenue Soars 638% Amidst Continued Losses, Strategic Rebrand — Nov 10, 2025 Risk: high
  Insight Molecular Diagnostics Inc. (IMDX) reported a significant increase in net revenue for the nine months ended September 30, 2025, reaching $2.916 million,
• IMDX Q2 Loss Widens to $10.9M Amid Revenue Dip — Aug 11, 2025 Risk: high
  Insight Molecular Diagnostics Inc. (IMDX) reported a net loss of $10.9 million for the three months ended June 30, 2025, a significant increase from the $7.8 mi
• Oncocyte Corp Files 10-Q for Q1 2025 — May 12, 2025 Risk: medium
  Oncocyte Corp filed a 10-Q for the period ending March 31, 2025. The company, formerly known as OncoCyte Corp, is involved in diagnostic substances. Key dates m
• Oncocyte Corp Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  Oncocyte Corp filed its 10-Q for the period ending September 30, 2024. The company reported sales revenue for the nine months ended September 30, 2024, and the
• Oncocyte Corp Files 10-Q for Q2 2024 — Aug 8, 2024 Risk: medium
  Oncocyte Corp filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key f
• Oncocyte Corp Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  Oncocyte Corp (IMDX) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Oncocyte Corp filed a 10-Q report for the period ending March 31, 2024. The f

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX